1. Home
  2. PPCB vs ISPC Comparison

PPCB vs ISPC Comparison

Compare PPCB & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.19

Market Cap

3.2M

Sector

N/A

ML Signal

N/A

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$0.25

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPCB
ISPC
Founded
2007
2009
Country
Australia
United States
Employees
N/A
24
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PPCB
ISPC
Price
$0.19
$0.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5M
934.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$9,291,115.00
Revenue This Year
N/A
$35.93
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.23
52 Week High
$10.69
$2.16

Technical Indicators

Market Signals
Indicator
PPCB
ISPC
Relative Strength Index (RSI) 33.67 37.70
Support Level $0.18 N/A
Resistance Level $0.40 $0.44
Average True Range (ATR) 0.03 0.03
MACD 0.01 -0.00
Stochastic Oscillator 22.28 14.02

Price Performance

Historical Comparison
PPCB
ISPC

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: